1.
AbbVie
2.
AbCellera
3.
AIM ImmunoTech
1990
4.
AI Therapeutics
2013
5.
AlloVir
2013
6.
Alnylam
9.
Athersys
1995
10.
Bayer
12.
Bellerophon Therapeutics
2009
13.
Beroni Group
2014
15.
Biocryst Pharma
16.
Biogen
1978
17.
CalciMedica Inc.
18.
Capricor Therapeutics
2005
20.
Celularity
2017
23.
Cipla
1935
25.
Cocrystal Pharma
2004
27.
CytoDyn Inc.
29.
Distributed Bio
2010
30.
Eli Lilly
33.
ETHRIS
34.
EUSA Pharma
36.
Geneyx
2018
37.
GigaGen
2010
40.
Grifols
1940
42.
Incyte Corp
43.
InflaRx
44.
Innocan
45.
Izana Bioscience
47.
Kamada
1990
50.
La jolla Pharmaceutical
1989
51.
Life Matters
2016
52.
LineaRx
53.
Mabpharm
54.
Macromoltek
55.
Mallinckrodt
56.
Mannin Research
58.
MediciNova
2000
59.
Merck KGaA
1668
60.
Mesoblast
2004
62.
NanoViricides
63.
Neurimmune Holding
2006
64.
NeuroRx
2015
65.
Novan
2008
66.
Novartis
67.
NovImmune
68.
Novoteris
69.
Onecell Medical
2017
70.
Pepticom
2011
71.
PharmaMar
72.
Pharmstandard
2003
73.
Pluristem Therapeutics
2003
75.
Q BioMed
2013
78.
Respinova
2008
80.
Roche Holding AG
82.
Sanofi
83.
SaNOtize
85.
Sorrento Therapeutics
2006
87.
Stero BioTech
90.
Takis Biotech
91.
Teva Pharmaceuticals
0
93.
Vanda Pharma
94.
Vero Biotech
2006
96.
Windtree Therapeutics
1992
98.
WuXi Biologics
«COVID-19 MedTech Industry Landscape by Sector»
- — organisation
- — investor and funding support bodies
- — hubs and other organisation types
Industries
© 2026